Pharmacokinetics and Pharmacodynamics for Co-Administration of Drugs
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 318
Special Issue Editors
Interests: pharmacokinetics; drug–drug interaction
Interests: clinical pharmacology; model-informed drug development; model-informed dose optimization; AI-driven drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is entitled “Pharmacokinetics (PK) and Pharmacodynamics (PD) for Co-Administration of Drugs”. Patients are often given two or more drugs at the same time to modulate the multiple pathophysiological mechanisms of a disease, to treat two or more coexisting diseases or symptoms, to induce a synergistic effect, or to counteract the side effects or resistance of drugs. Pharmacokinetic or pharmacodynamic drug interactions among co-administered drugs are a source of variability in clinical drug response. The Special Issue aims to cover the following topics: (a) clinical/preclinical PK/PD studies to investigate drug interactions among co-administered drugs; (b) PK/PD modeling, in silico prediction or machine learning applications to predict drug interactions; (c) drug–drug–gene interactions, polymorphisms of enzymes, transporters, and receptors involved in the various reactions of drug interactions; (d) PK/PD of co-administered herbal/biologic products; (e) drug interactions on side effects of drugs; (f) overview of the current trends/hurdles of PK/PD studies or guidelines for combination drug therapy.
Dr. Namyi Gu
Dr. Kwang-Hee Shin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- co-administration
- drug interaction
- pharmacokinetics
- pharmacodynamics
- in silico simulation
- machine learning
- polymorphism
- biologic product
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
